Wells Fargo
ELOX

Wells Fargo’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Wells Fargo’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,172
Closed -$5.64K – 7853
2023
Q3 		$5.64K Buy
1,172
+4
+0.3% +$22 ﹤0.01% 5938
2023
Q2 		$4.54K Buy
1,168
+1
+0.1% +$6 ﹤0.01% 6090
2023
Q1 		$2.93K Hold
1,167
– – ﹤0.01% 6169
2022
Q4 		$2.12K Sell
1,167
-1
-0.1% -$5 ﹤0.01% 6003
2022
Q3 		$8K Hold
1,168
– – ﹤0.01% 5796
2022
Q2 		$13K Buy
1,168
+1
+0.1% +$14 ﹤0.01% 5658
2022
Q1 		$26K Hold
1,167
– – ﹤0.01% 5933
2021
Q4 		$33K Buy
1,167
+633
+119% +$27.6K ﹤0.01% 6164
2021
Q3 		$36K Sell
534
-2
-0.4% -$123 ﹤0.01% 5753
2021
Q2 		$43K Buy
536
+209
+64% +$17.4K ﹤0.01% 5627
2021
Q1 		$44K Sell
327
-618
-65% -$94.5K ﹤0.01% 5878
2020
Q4 		$151K Buy
945
+224
+31% +$27.4K ﹤0.01% 5199
2020
Q3 		$75K Sell
721
-178
-20% -$21.3K ﹤0.01% 5364
2020
Q2 		$109K Buy
899
+324
+56% +$36.7K ﹤0.01% 5188
2020
Q1 		$45K Sell
575
-223
-28% -$36.3K ﹤0.01% 5380
2019
Q4 		$235K Sell
798
-182
-19% -$36.7K ﹤0.01% 4855
2019
Q3 		$178K Sell
980
-14
-1% -$3.98K ﹤0.01% 5033
2019
Q2 		$396K Sell
994
-64
-6% -$26.9K ﹤0.01% 4541
2019
Q1 		$494K Buy
1,058
+147
+16% +$71.4K ﹤0.01% 4342
2018
Q4 		$438K Buy
911
+630
+224% +$348K ﹤0.01% 4417
2018
Q3 		$192K Buy
281
+23
+9% +$14.7K ﹤0.01% 5030
2018
Q2 		$176K Buy
+258
New +$167K ﹤0.01% 5099

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Wells Fargo's ELOX Position: Q4 2023 in Review

Wells Fargo sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 1,172 shares — an estimated $5.64K sold.

Wells Fargo first reported a position in ELOX in Q2 2018 and held it in 22 quarters. The position peaked at $494K in Q1 2019. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

  • Wells Fargo reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Wells Fargo sold 1,172 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $5.64K.
  • Wells Fargo first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 22 quarters.
  • Wells Fargo's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $494K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.